American Journal of Infection Control

The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan, China in December 2019, and was officially declared a global pandemic by the World Health

Infection prevention professionals (IPs) reduce and eliminate hospital associated infections (HAIs) through evidence-based infection control programming within health care systems. IPs come from diverse professional backgrounds (eg, epidemiologists

The South Carolina Department of Health and Environmental Control (SCDHEC) was notified of a Klebsiella pneumoniae NDM isolated from a respiratory specimen of a patient in a dedicated Coronavirus Disease 2019 (COVID-19) intensive care unit (ICU) at

The increasing spread of antimicrobial resistance (AMR) represents a global public health threat, and a significant challenge for healthcare delivery.1,2 Inappropriate or excessive antibiotic use are important drivers of AMR, due to the ecological

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant spread rapidly worldwide and was reported in 185 countries by September 2021.1 Although vaccination is the cornerstone of protection against SARS-CoV-2, breakthrough

Over 2.8 million people are infected with, and 35,000 people die from antibiotic-resistant bacteria annually in the United States.1 Injudicious outpatient use of antibiotics contributes to the growth of antibiotic-resistant bacteria and reduced

Healthcare-associated infections (HAIs) are one of the most common adverse events in patient care that account for substantial morbidity and mortality. We evaluate the existing Infection Prevention and Control (IPC) practices in hospitals

Clostridioides difficile is a Gram positive, spore-forming bacterium, transmitted via the fecal-oral route. C. difficile infection (CDI) occurs when the bacterium produces toxins, causing diarrhea and inflammation of the colon. Risk factors that have

Although the SARS-COV-2 virus is a serious threat to population health in all jurisdictions, the response to this pandemic has varied substantially across the United States. While vaccines offer some protection against severe morbidity and mortality

Over 3 million patients annually receive home and specialty infusion services, typically through maintaining central venous catheters (CVCs) in the home for indications such as chemotherapy, home parenteral nutrition (HPN), and outpatient parenteral